About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
CRIPS is a research group focusing on severe acute respiratory infections and sepsis.
The objective is to develop projects on clinical and translational research in hospital-acquired pneumonia, community-acquired pneumonia, and severe viral respiratory infections, such as influenza and COVID-19. CRIPS also develop epidemiological studies focused on risk and prognostic factors for multi-resistant pathogens, validation of ventilator-associated events in ventilated adult and pediatric patients, incorporating artificial intelligence techniques. It also highlights evidence-based medicine (EBM) research, evaluating therapies and prevention strategies and participating in the formulation of clinical practice guidelines, as part of CIBERES and the European Society for Clinical Microbiology and Infections. The EBM research focuses on knowledge translation to get research findings to the point of decision making, providing health-related recommendations, focusing on clinical research and relevance of care.
CRIPS collaborate on a Local (UIC, IDIAP), National (CIBERES), and International level (CHU Nimes, Uolo University, ISARIC and Pneumo-Inspire Networks).
PMID: 32379379 Journal: International Wound Journal Year: 2020 Reference: Int Wound J. 2020 Oct;17(5):1520-1522. doi: 10.1111/iwj.13397. Epub 2020 May 7. Impact factor: 2.825 Publication type: Letter or abstract Authors: Tammaro, Antonella, Sernicola, Alvise, Chello, Camilla, Cerbelli, Edoardo, Adebanjo, Ganiyat Adenike Ralitsa, Parisella, Francesca Romana, Pezzuto, Aldo, Luzi, Fabiola, De Marco, Gabriella, Rello, Jordi et al. DOI: 10.1111/iwj.13397
PMID: 32347523 Journal: ADVANCES IN THERAPY Year: 2020 Reference: Adv Ther. 2020 Jun;37(6):2646-2666. doi: 10.1007/s12325-020-01347-5. Epub 2020 Apr 28. Impact factor: 3.871 Publication type: Review in international publication Authors: Tejada, Sofia, Campogiani, Laura, Sole-Lleonart, Candela, Rello, Jordi et al. DOI: 10.1007/s12325-020-01347-5
PMID: 32341111 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2020 Reference: Eur Respir J. 2020 May 21;55(5). pii: 13993003.01028-2020. doi: 10.1183/13993003.01028-2020. Print 2020 May. Impact factor: 12.339 Publication type: Paper in international publication Authors: Rello, Jordi, Storti, Enrico, Belliato, Mirko, Serrano, Ricardo et al. DOI: 10.1183/13993003.01028-2020
PMID: 32330340 Journal: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY Year: 2020 Reference: J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e306-e307. doi: 10.1111/jdv.16530. Impact factor: 5.248 Publication type: Letter or abstract Authors: Tammaro, A, Adebanjo, G A R, Parisella, F R, Pezzuto, A, Rello, J et al. DOI: 10.1111/jdv.16530
PMID: 21310059 Journal: CRITICAL CARE Year: 2011 Reference: Crit Care. 2011;15(1):R57. doi: 10.1186/cc10030. Epub 2011 Feb 10. Impact factor: 4.595 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1186/cc10030
PMID: 21301334 Journal: CURRENT OPINION IN INFECTIOUS DISEASES Year: 2011 Reference: Curr Opin Infect Dis. 2011 Apr;24(2):137-41. Impact factor: 5.167 Publication type: Review in international publication Authors: , et al. DOI: 10.1097/QCO.0b013e328343b70d
PMID: 21196562 Journal: AMERICAN JOURNAL OF CRITICAL CARE Year: 2011 Reference: Am J Crit Care. 2011 Jan;20(1):e1-9. Impact factor: 1.593 Publication type: Paper in international publication Authors: Blot, Stijn I, Serra, Mireia Llaurado, Macor, Antonio, Manno, Emilpaolo, Manez, Rafael, Marsh, Brian, Martin, Claude, Martin-Loeches, Ignacio, Myrianthefs, Pavlos, Nauwynck, Marc et al. DOI: 10.4037/ajcc2011555
PMID: 21263317 Journal: CRITICAL CARE MEDICINE Year: 2011 Reference: Crit Care Med. 2011 May;39(5):945-51. Impact factor: 6.254 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1097/CCM.0b013e318208ee12
A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.
The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men
The scientific review reports that changes in the respiratory system flora due to pollution increase the risk of suffering a hospital infection caused by multidrug-resistant organisms.
